Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Chariot Capital Group acquires Laser Clinics UK

hariot Capital Group, a US-based private equity firm specialising in corporate carve-outs, divestitures, and complex transactions, has acquired Laser Clinics UK, the UK arm of Australia-and UK-based medical aesthetics services chain Laser Clinics Group.
June 18, 2026

Motion Equity Partners acquires Polaris

French private equity firm Motion Equity Partners has announced the acquisition of France-based biotech firm Polaris, which produces highly concentrated omega-3 from microalgae.
June 17, 2026

Oxford Biomedica potentially open to private equity offers

UK-based Contract Development Manufacturing Organisation (CDMO) Oxford Biomedica (OXB) may be open to a private equity takeover, provided any offer meets the company's valuation expectations and supports its long-term growth ambitions.
June 17, 2026

GSK acquires Nuvalent for $10.6 billion

British drugmaker GSK has acquired Nuvalent, a Boston-based clinical-stage biopharmaceutical company focused on precisely targeted oncology therapies, for an equity value of $10.6 billion (~£8 billion).
June 17, 2026

Structural tailwinds from hospital reform driving growth in German outpatient intensive care sector- Dr Erik Hamann, Opseo 

Germany’s outpatient intensive care market is entering a period of structural change, creating significant opportunities for providers with scale, according to Dr Erik Hamann, CEO of Opseo, a German provider of intensive care services. HBI recently spoke to Hamann about Germany’s hospital reform, increasing regulatory complexity and ongoing market consolidation. These trends are reshaping the […]
June 16, 2026

Huron acquires RelateCare from MML Ireland

Huron, a Nasdaq-listed global professional services firm, has acquired AI-enabled clinical and patient access solutions provider RelateCare from private equity firm MML Growth Capital Partners Ireland.
June 11, 2026

Bridgepoint to acquire Obagi Medical from Waldencast

Mid-market private equity firm Bridgepoint Group has agreed to acquire US-based Obagi Medical, a dermatological skincare and aesthetics business, from Nasdaq-listed beauty and wellness group Waldencast, for an enterprise value of up to $460 million (~€399.00 million).
June 11, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us